Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.

CNS lymphoma investigations malignancy ocular tumor prognosis treatment

Journal

Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512

Informations de publication

Date de publication:
2019
Historique:
entrez: 13 3 2019
pubmed: 13 3 2019
medline: 13 3 2019
Statut: epublish

Résumé

Primary vitreoretinal lymphoma (PVRL) is a rare and potentially fatal intraocular malignancy. More than half of PVRL cases eventually involve the central nervous system (CNS). PVRL frequently masquerades as chronic uveitis. Advanced imaging tests, such as optical coherence tomography and fundus autofluorescence, have been applied in the diagnosis of PVRL. Histology and immunohistochemistry, in combination with molecular tests and IL-10 analysis, have been demonstrated as reliable in diagnosing PVRL. Mortality is high in patients with PVRL associated with CNS involvement, and relapses are common. The use of systemic chemotherapy in addition to the local therapies has proved to extend the mean survival time of these patients. Local therapies, including intravitreal injections of methotrexate and/or rituximab and low-dose radiotherapy to the eye, have been shown to be extremely effective in controlling intraocular lymphoma.

Identifiants

pubmed: 30858685
doi: 10.2147/OPTH.S159014
pii: opth-13-353
pmc: PMC6387616
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

353-364

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Br J Ophthalmol. 1999 Apr;83(4):448-51
pubmed: 10434868
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2462-3
pubmed: 10476821
Ophthalmology. 1999 Sep;106(9):1805-10
pubmed: 10485554
J Neurooncol. 1999 Jul;43(3):199-201
pubmed: 10563423
J Neurooncol. 1999 Jul;43(3):227-30
pubmed: 10563427
Arch Ophthalmol. 2000 Mar;118(3):446
pubmed: 10721983
Surv Ophthalmol. 2000 May-Jun;44(6):518-26
pubmed: 10906383
Ophthalmology. 2000 Aug;107(8):1479-82
pubmed: 10919894
Arch Ophthalmol. 2000 Oct;118(10):1437-40
pubmed: 11030832
J Clin Oncol. 2001 Feb 1;19(3):742-9
pubmed: 11157026
Ocul Immunol Inflamm. 2000 Dec;8(4):243-50
pubmed: 11262654
Curr Opin Oncol. 2001 May;13(3):137-42
pubmed: 11307054
Retina. 2001;21(3):281-4
pubmed: 11421029
Mod Pathol. 2001 Oct;14(10):995-9
pubmed: 11598169
Retina. 2002 Feb;22(1):37-43
pubmed: 11884876
Curr Mol Med. 2001 May;1(2):259-72
pubmed: 11899075
Lancet Oncol. 2001 Jun;2(6):354-65
pubmed: 11905752
Ann Oncol. 2002 Apr;13(4):531-8
pubmed: 12056702
Curr Treat Options Oncol. 2001 Aug;2(4):309-18
pubmed: 12057111
Ophthalmic Surg Lasers. 2002 Jul-Aug;33(4):329-33
pubmed: 12134997
Ophthalmology. 2003 Feb;110(2):421-6
pubmed: 12578791
Clin Exp Ophthalmol. 2003 Apr;31(2):155-8
pubmed: 12648051
Ophthalmology. 2003 Jun;110(6):1241-4
pubmed: 12799254
Eye (Lond). 2003 May;17(4):513-21
pubmed: 12802353
Clin Lymphoma. 2003 Jun;4(1):22-9
pubmed: 12837150
Am J Ophthalmol. 1955 Jan;39(1):29-32
pubmed: 13218108
Graefes Arch Clin Exp Ophthalmol. 2003 Oct;241(10):860-70
pubmed: 14605902
Am J Ophthalmol. 1951 Aug;34(8):1153-8
pubmed: 14857107
Methods Mol Biol. 2004;248:503-18
pubmed: 14970517
Br J Haematol. 2004 Jul;126(2):202-8
pubmed: 15238140
Am J Ophthalmol. 2004 Aug;138(2):306-8
pubmed: 15289150
Graefes Arch Clin Exp Ophthalmol. 2004 Sep;242(9):771-6
pubmed: 15349786
Ophthalmology. 2004 Sep;111(9):1762-7
pubmed: 15350334
Cancer Control. 2004 Sep-Oct;11(5):285-95
pubmed: 15377987
Ophthalmology. 1992 Feb;99(2):250-6
pubmed: 1553217
Graefes Arch Clin Exp Ophthalmol. 2004 Nov;242(11):901-13
pubmed: 15565454
Ophthalmol Clin North Am. 2005 Mar;18(1):177-85, x
pubmed: 15763203
Retina. 2005 Apr-May;25(3):370-3
pubmed: 15805919
Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):189-97
pubmed: 15806372
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2495-502
pubmed: 15980241
Hematol Oncol. 2004 Dec;22(4):143-58
pubmed: 16134191
Ann Oncol. 2005 Dec;16(12):1974-8
pubmed: 16219622
Graefes Arch Clin Exp Ophthalmol. 2006 Jun;244(6):663-9
pubmed: 16228920
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):3957-64
pubmed: 16249468
Am J Ophthalmol. 2005 Nov;140(5):822-829
pubmed: 16310459
Eye (Lond). 2007 Sep;21(9):1198-201
pubmed: 16732210
J Clin Oncol. 2006 Aug 20;24(24):3865-70
pubmed: 16864853
Jpn J Ophthalmol. 2006 Sep-Oct;50(5):474-478
pubmed: 17013703
Cancer Res. 2006 Nov 1;66(21):10586-93
pubmed: 17079483
Ophthalmology. 2007 Jul;114(7):1372-7
pubmed: 17324466
Int Ophthalmol. 2007 Aug;27(4):241-50
pubmed: 17440686
Eye (Lond). 2008 Feb;22(2):289-93
pubmed: 17767143
Ann Oncol. 2007 Nov;18(11):1851-5
pubmed: 17804469
Br J Ophthalmol. 2008 Mar;92(3):383-8
pubmed: 18303160
J Clin Oncol. 2008 May 20;26(15):2512-8
pubmed: 18413641
Jpn J Ophthalmol. 2008 May-Jun;52(3):167-174
pubmed: 18661266
Neurology. 2008 Oct 21;71(17):1355-60
pubmed: 18936428
Clin Exp Ophthalmol. 2008 Aug;36(6):564-78
pubmed: 18954321
J Neurooncol. 2009 Jun;93(2):213-7
pubmed: 19099202
Prog Retin Eye Res. 2009 Mar;28(2):117-44
pubmed: 19114125
Retina. 2009 Mar;29(3):415-6
pubmed: 19174721
Am J Ophthalmol. 2009 May;147(5):886-94, 894.e1
pubmed: 19243734
Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):69-72
pubmed: 19412864
Ocul Immunol Inflamm. 2009 May-Jun;17(3):133-41
pubmed: 19585354
Ocul Immunol Inflamm. 2009 May-Jun;17(3):142-7
pubmed: 19585355
Arch Pathol Lab Med. 2009 Aug;133(8):1233-7
pubmed: 19653716
Ocul Immunol Inflamm. 2009 Jul-Aug;17(4):227-37
pubmed: 19657975
Korean J Ophthalmol. 2009 Sep;23(3):210-4
pubmed: 19794951
Ocul Immunol Inflamm. 2009 Sep-Oct;17(5):299-306
pubmed: 19831557
Br J Ophthalmol. 2010 May;94(5):633-8
pubmed: 20447965
Int J Mol Sci. 2011;12(9):5684-97
pubmed: 22016619
Oncologist. 2011;16(11):1589-99
pubmed: 22045784
J Ophthalmic Inflamm Infect. 2012 Mar;2(1):49-51
pubmed: 22071869
Haematologica. 2012 Nov;97(11):1751-6
pubmed: 22581000
Graefes Arch Clin Exp Ophthalmol. 2012 Oct;250(10):1541-8
pubmed: 22628023
Continuum (Minneap Minn). 2012 Apr;18(2):406-15
pubmed: 22810135
Eye (Lond). 2013 Feb;27(2):153-62
pubmed: 23196650
JAMA Ophthalmol. 2013 Jan;131(1):50-5
pubmed: 23307208
Ophthalmology. 2013 May;120(5):991-6
pubmed: 23380473
Discov Med. 2013 Feb;15(81):93-100
pubmed: 23449111
PLoS One. 2013 Aug 05;8(8):e71754
pubmed: 23940785
Retina. 2014 Feb;34(2):366-72
pubmed: 23958842
J Ophthalmic Inflamm Infect. 2013 Sep 08;3(1):59
pubmed: 24011267
Transl Vis Sci Technol. 2012 Oct 22;1(3):1
pubmed: 24049708
Clin Ophthalmol. 2014 Jan 31;8:335-41
pubmed: 24520190
Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):687-93
pubmed: 24549401
Surv Ophthalmol. 2014 Sep-Oct;59(5):503-16
pubmed: 24560125
Eur J Ophthalmol. 2014 Nov-Dec;24(6):911-7
pubmed: 24846625
JAMA Ophthalmol. 2015 Feb;133(2):191-7
pubmed: 25412269
Retina. 2015 Apr;35(4):624-7
pubmed: 25768255
Blood. 2015 Jul 2;126(1):76-9
pubmed: 25900979
Indian J Ophthalmol. 2015 Mar;63(3):180-6
pubmed: 25971162
Lancet Oncol. 2015 Jul;16(7):e322-32
pubmed: 26149884
Nat Med. 2015 Aug;21(8):922-6
pubmed: 26193343
Curr Opin Ophthalmol. 2016 May;27(3):177-84
pubmed: 26859131
Lancet Haematol. 2016 May;3(5):e217-27
pubmed: 27132696
Br J Haematol. 2016 Jun;173(5):680-92
pubmed: 27133587
Asia Pac J Ophthalmol (Phila). 2017 May-Jun;6(3):283-289
pubmed: 28558176
Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):783-796
pubmed: 29126866
Ocul Oncol Pathol. 2017 Nov;3(4):324-327
pubmed: 29344490
Int J Retina Vitreous. 2018 May 7;4:18
pubmed: 29760948
Ophthalmology. 1988 May;95(5):625-30
pubmed: 3050698
Br J Ophthalmol. 1988 Dec;72(12):905-11
pubmed: 3067746
Acta Cytol. 1988 Nov-Dec;32(6):840-7
pubmed: 3264435
J Neurosurg. 1988 Jun;68(6):835-53
pubmed: 3286832
Ophthalmology. 1987 Dec;94(12):1631-9
pubmed: 3323986
Can J Ophthalmol. 1986 Jun;21(4):144-9
pubmed: 3755372
Cancer. 1983 Sep 1;52(5):878-86
pubmed: 6347357
Retina. 1984 Summer-Fall;4(3):135-43
pubmed: 6387833
Cancer. 1980 Feb 15;45(4):688-92
pubmed: 6766795
Am J Ophthalmol. 1995 Nov;120(5):671-3
pubmed: 7485372
Surv Ophthalmol. 1994 Sep-Oct;39(2):133-40
pubmed: 7801221
Arch Ophthalmol. 1994 Apr;112(4):450-1
pubmed: 8155047
Cancer. 1993 Aug 1;72(3):843-9
pubmed: 8334638
Mayo Clin Proc. 1993 Oct;68(10):1011-5
pubmed: 8412351
Am J Ophthalmol. 1996 Apr;121(4):442-4
pubmed: 8604740
Arch Pathol Lab Med. 1996 Apr;120(4):357-63
pubmed: 8619747
Leuk Lymphoma. 1996 Oct;23(3-4):339-45
pubmed: 9031115
Graefes Arch Clin Exp Ophthalmol. 1997 Jul;235(7):431-6
pubmed: 9248839
Arch Ophthalmol. 1997 Sep;115(9):1152-6
pubmed: 9298056
Am J Ophthalmol. 1997 Sep;124(3):362-72
pubmed: 9439362
Diagn Mol Pathol. 1998 Feb;7(1):63-4
pubmed: 9646037
Ophthalmology. 1998 Sep;105(9):1659-63
pubmed: 9754174
Ophthalmology. 1998 Sep;105(9):1664-9
pubmed: 9754175

Auteurs

Ramesh Venkatesh (R)

Department of Retina and Vitreous, Narayana Nethralaya, Bengaluru - 560010, India, vramesh80@yahoo.com.

Bharathi Bavaharan (B)

Department of Retina and Vitreous, Narayana Nethralaya, Bengaluru - 560010, India, vramesh80@yahoo.com.

Padmamalini Mahendradas (P)

Department of Uvea and Intraocular Inflammation, Narayana Nethralaya, Bengaluru - 560010, India.

Naresh Kumar Yadav (NK)

Department of Retina and Vitreous, Narayana Nethralaya, Bengaluru - 560010, India, vramesh80@yahoo.com.

Classifications MeSH